These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21400751)

  • 1. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
    Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
    Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia].
    Zadnipryanyi IV; Tretyakova OS; Sataeva TP
    Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
    Karpishchenko SN; Zheregelia SN; Glushkov SI
    Eksp Klin Farmakol; 2010 Oct; 73(10):40-2. PubMed ID: 21254514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
    Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
    Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
    Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
    Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
    Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
    Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant therapy in discirculatory encephalopathy].
    Antipenko EA; Gustov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
    Beĭn BN; Dravert NE
    Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antioxidant protection as a component of anesthetic management cancer patients].
    Tumanian SV; Ivanova LG
    Khirurgiia (Mosk); 2011; (6):66-9. PubMed ID: 21716223
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of cytoflavin in sports nutrition].
    Kosinets VA; Stolbitskiĭ VV; Shturich IP
    Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
    Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
    Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoflavin in total intravenous anesthesia].
    Ovezov AM; Bragina SV; Prokoshev PV
    Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
    Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
    Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
    Lavrik SIu; Domitrak SV; Shprakh VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):37-41. PubMed ID: 21512499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of metabolic disturbances in cancer patients in the early postanesthesia period].
    Fatullaeva KF; Nurov AU; Saltanov AI
    Khirurgiia (Mosk); 2010; (4):54-7. PubMed ID: 20521428
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
    Kliuĭko DA; Korik VE; Zhidkov SA
    Eksp Klin Farmakol; 2011; 74(9):11-5. PubMed ID: 22164440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
    Mikhaĭlova EV; Danilova AN; Chudakova TK; Romanovskaia AV; Dubovitskaia NA; Belova AE
    Eksp Klin Farmakol; 2013; 76(8):43-6. PubMed ID: 24228490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.